IRIDEX CORP

Analysis for Ticker: IRIX

Iridex Corporation is a medical technology firm that sells laser systems and disposable tools like EndoProbe to treat eye conditions including glaucoma and retina diseases. While it markets these specialized devices, the company is effectively a biological host for a 92,4$ million accumulated deficit. The core financial crime is a debt structure that forces the company to print new stock to pay its interest because it has run out of actual money. This creates a mathematical death spiral where every quarterly payment dilutes existing owners closer to zero, treating the company's own stock like counterfeit currency to keep the debt alive.